Sr. Director, Biomarker & Companion Diagnostic Development

Looking for a chance to make a meaningful difference in the oncology space? Taiho Oncology is on a mission: to improve the lives of patients with cancer, their families, and caregivers.

Our “People first” approach means we also highly value our employees, who work relentlessly to help execute our mission.

Taiho’s success is founded on ensuring we always act with accountability, collaboration, and trust.

By following these guiding principles, we earn and maintain the confidence of patients, the global healthcare community, collaborators and partners, and each other.

Together, we are working on cutting-edge science and growing our portfolio and pipeline across a range of tumor types to address the ongoing and evolving needs of patients.

Advanced technology, a world-class clinical development organization, and state-of-the-art facilities: these and other resources empower us to innovate and touch the lives of more and more patients.

It’s our work, our passion, and our legacy.

We invite you to join us.  

Hybrid  

Employee Value Proposition: 

At Taiho Oncology, we are dedicated to transforming the landscape of cancer treatment and improving patients' lives.

As a Senior Director, Biomarkers and CDx Development, you will play a pivotal role in our mission, leveraging your expertise to drive innovative precision medicine strategies and contribute to groundbreaking therapies.

We offer a collaborative and inclusive work environment where your ideas and contributions are valued.

Join us to advance your career, work with passionate and skilled professionals, and make a meaningful impact on the fight against cancer.

At Taiho Oncology, you will find purpose, growth, and the opportunity to be at the forefront of cancer research. 

  

Position Summary: 


* Reporting to VP, Biomarker and Companion Diagnostic Development, this position has responsibility for the strategy related to the identification and selection of clinical biomarkers to be incorporated into early-stage clinical trials in collaboration with TPC’s research organization and, where appropriate, for the further development, registration and approval of companion diagnostics.  Works cross-functionally with internal departments and external partners. 

Performance Objectives: 


* Design of biomarkers strategy in collaboration with Taiho Japan and/or Taiho Oncology Inc (TOI) GPDT members  


* Develop Companion Diagnostic strategy for relevant compounds. 


* Responsible for execution of translational and biomarkers aspects within Phase1-3 studies for US and EU or global studies. 


* Responsible for liaising with Clinical Development Leads in Clinical Development in implementing the biomarker strategies. 


* Collaborates with relevant departments within TOI to establish operational plans and timelines/cost for respective studies within each of the development programs  


* Creating/reviewing and editing biomarkers aspects in various documents a...